what is better for weight loss semaglutide or tirzepatide vs Semaglutide: Which Medication Works Better? Semaglutide vs. Tirzepatide for weight
Description
Conclusions Patients with T2D and CKD are at high risk for adverse cardiovascular and kidney outcomes and require a multipronged approach to risk reduction
They are quite common and can affect between 30 and 50% of women of reproductive age
However, it carries a known risk of hypophosphatemia (low phosphorus), especially with repeated doses
The cardiovascular benefits, demonstrated in the SELECT trial showing reduced heart attack and stroke risk with semaglutide, actually argue in favor of continued use for people with cardiovascular risk factors
